• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

大鼠体内苯妥英代谢生成5-(3,4-二羟基苯基)-5-苯乙内酰脲的性别差异。

Sex differences in rats in the metabolism of phenytoin to 5-(3,4-dihydroxyphenyl)-5-phenylhydantoin.

作者信息

Billings R E

出版信息

J Pharmacol Exp Ther. 1983 Jun;225(3):630-6.

PMID:6864524
Abstract

Phenytoin (DPH) is metabolized in isolated hepatocytes from male rats by hydroxylation to 5-(4-hydroxyphenyl)-5-phenylhydantoin, 5-(3,4-dihydroxy-1,5-cyclohexadien-1-yl)-5-phenylhydantoin (dihydrodiol) and a catecholic metabolite, 5-(3,4-dihydroxyphenyl)-5-phenylhydantoin, which is further metabolized by methylation of one of the phenolic hydroxyl groups. Isolated hepatocytes from female rats convert DPH to the initial metabolites, but only trace amounts of the catechol are formed. Similar results were obtained in vivo and with liver homogenate preparations. Incubation of possible precursor metabolites to the catechol indicate that the sex difference in catechol formation is due to differences in 5-(4-hydroxyphenyl)-5-phenylhydantoin hydroxylation rather than to differences in oxidation of the dihydrodiol metabolite. It is postulated that different isozymes of cytochrome P-450 catalyze the hydroxylation of DPH and its p-phenol metabolite because sex differences are observed only in the second hydroxylation step. Furthermore, the sex difference may be due to lower activity of one or more cytochrome P-450 isozymes in female rats than in male rats. These results may have important implications in the pharmacological activity and toxicity of DPH.

摘要

苯妥英(DPH)在雄性大鼠的离体肝细胞中通过羟基化代谢为5-(4-羟基苯基)-5-苯基乙内酰脲、5-(3,4-二羟基-1,5-环己二烯-1-基)-5-苯基乙内酰脲(二氢二醇)和一种儿茶酚代谢物5-(3,4-二羟基苯基)-5-苯基乙内酰脲,后者通过其中一个酚羟基的甲基化进一步代谢。雌性大鼠的离体肝细胞将DPH转化为初始代谢物,但仅形成痕量的儿茶酚。在体内和肝脏匀浆制剂中也获得了类似的结果。对儿茶酚可能的前体代谢物进行孵育表明,儿茶酚形成的性别差异是由于5-(4-羟基苯基)-5-苯基乙内酰脲羟基化的差异,而不是二氢二醇代谢物氧化的差异。据推测,细胞色素P-450的不同同工酶催化DPH及其对苯酚代谢物的羟基化,因为仅在第二步羟基化中观察到性别差异。此外,性别差异可能是由于雌性大鼠中一种或多种细胞色素P-450同工酶的活性低于雄性大鼠。这些结果可能对DPH的药理活性和毒性具有重要意义。

相似文献

1
Sex differences in rats in the metabolism of phenytoin to 5-(3,4-dihydroxyphenyl)-5-phenylhydantoin.大鼠体内苯妥英代谢生成5-(3,4-二羟基苯基)-5-苯乙内酰脲的性别差异。
J Pharmacol Exp Ther. 1983 Jun;225(3):630-6.
2
Bioactivation of phenytoin by human cytochrome P450: characterization of the mechanism and targets of covalent adduct formation.人细胞色素P450对苯妥英的生物活化:共价加合物形成机制及靶点的表征
Chem Res Toxicol. 1997 Sep;10(9):1049-58. doi: 10.1021/tx9700836.
3
Oxygen-18 incorporation studies of the metabolism of phenytoin to the catechol.
Drug Metab Dispos. 1985 May-Jun;13(3):312-7.
4
Evidence for an arene oxide-NIH shift pathway in the metabolic conversion of phenytoin to 5-(4-hydroxyphenyl)-5-phenylhydantoin in the rat and in man.
Drug Metab Dispos. 1982 Nov-Dec;10(6):667-71.
5
NTP technical report on the toxicity and metabolism studies of chloral hydrate (CAS No. 302-17-0). Administered by gavage to F344/N rats and B6C3F1 mice.国家毒理学计划关于水合氯醛(化学物质登记号:302-17-0)毒性和代谢研究的技术报告。通过灌胃法给予F344/N大鼠和B6C3F1小鼠。
Toxic Rep Ser. 1999 Aug(59):1-66, A1-E7.
6
Phenytoin metabolism in mice.
Drug Metab Dispos. 1982 Mar-Apr;10(2):156-60.
7
Evidence for an arene-3,4-oxide as a metabolic intermediate in the meta- and para-hydroxylation of phenytoin in the dog.
Drug Metab Dispos. 1983 Nov-Dec;11(6):574-80.
8
Hydroxylation of 5,5-diphenylhydantoin (phenytoin) by dog liver microsomes.
Arch Int Pharmacodyn Ther. 1977 Jul;228(1):4-9.
9
Stereoselective inhibition of diphenylhydantoin metabolism by p-hydroxyphenyl-phenylhydantoin enantiomers in rats.大鼠体内对羟基苯基苯妥英对映体对苯妥英代谢的立体选择性抑制作用。
Chirality. 1991;3(6):454-9. doi: 10.1002/chir.530030608.
10
Influence of pregnancy and folic acid on phenytoin metabolism by rat liver microsomes.妊娠和叶酸对大鼠肝脏微粒体苯妥英代谢的影响。
Drug Metab Dispos. 1978 May-Jun;6(3):246-50.

引用本文的文献

1
Piperazine ring toxicity in three novel anti-breast cancer drugs: an in silico and in vitro metabolic bioactivation approach using olaparib as a case study.哌嗪环毒性在三种新型抗乳腺癌药物中的研究:以奥拉帕利为例的体外代谢生物活化方法的计算研究。
Naunyn Schmiedebergs Arch Pharmacol. 2023 Jul;396(7):1435-1450. doi: 10.1007/s00210-023-02413-9. Epub 2023 Feb 4.
2
Development and validation of an HPLC-MS/MS method for the determination of arginine-vasopressin receptor blocker conivaptan in human plasma and rat liver microsomes: application to a metabolic stability study.用于测定人血浆和大鼠肝微粒体中精氨酸加压素受体阻断剂考尼伐坦的HPLC-MS/MS方法的建立与验证:在代谢稳定性研究中的应用
Chem Cent J. 2018 May 2;12(1):47. doi: 10.1186/s13065-018-0414-5.
3
Isatin-benzoazine molecular hybrids as potential antiproliferative agents: synthesis and in vitro pharmacological profiling.异吲哚酮-苯并嗪分子杂化物作为潜在的抗增殖剂:合成与体外药理学分析
Drug Des Devel Ther. 2017 Aug 9;11:2333-2346. doi: 10.2147/DDDT.S140164. eCollection 2017.
4
Validated LC-MS/MS Method for the Quantification of Ponatinib in Plasma: Application to Metabolic Stability.用于定量测定血浆中波纳替尼的经过验证的液相色谱-串联质谱法:在代谢稳定性研究中的应用
PLoS One. 2016 Oct 20;11(10):e0164967. doi: 10.1371/journal.pone.0164967. eCollection 2016.